NasdaqGS:ADPTLife Sciences
A Look At Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness
Why Adaptive Biotechnologies Is Drawing Attention Now
Adaptive Biotechnologies (ADPT) is back on investor radars after recent share price weakness. The stock has shown negative returns over the past week, month, and past 3 months, while still delivering a strongly positive 1 year total return.
See our latest analysis for Adaptive Biotechnologies.
The recent 1 day share price decline of 11.1% to US$12.41 adds to weak short term momentum, with 30 day and 90 day share price returns both firmly...